Search

Your search keyword '"Gil, Jeovanis"' showing total 141 results

Search Constraints

Start Over You searched for: Author "Gil, Jeovanis" Remove constraint Author: "Gil, Jeovanis" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
141 results on '"Gil, Jeovanis"'

Search Results

4. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies

6. Novel functional proteins coded by the human genome discovered in metastases of melanoma patients

8. Clinical protein science in translational medicine targeting malignant melanoma

9. Mitochondrial and immune response dysregulation in melanoma recurrence

10. Histopathology-assisted proteogenomics provides foundations for stratification of melanoma metastases

14. Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies

15. Supplementary Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer

16. Supplementary Table S1 from Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity

17. Data from Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer

18. Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction, progression, and prion-like spread of Alzheimer’s disease pathogenesis

19. Proteogenomic Characterization Reveals Therapeutic Opportunities Related to Mitochondrial Function in Melanoma

21. Lipid Metabolic Reprogramming Extends beyond Histologic Tumor Demarcations in Operable Human Pancreatic Cancer

22. The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition

23. Quantitative Proteomic Analysis of Cervical Cancer Tissues Identifies Proteins Associated With Cancer Progression

24. Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease

25. Deep Proteomic Analysis on Biobanked Paraffine-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out

26. An Observational Study on the Molecular Profiling of Primary Melanomas Reveals a Progression Dependence on Mitochondrial Activation

28. Human iPSC-derived hippocampal spheroids: An innovative tool for stratifying Alzheimer disease patient-specific cellular phenotypes and developing therapies

29. Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer’s Disease

30. A biobanking turning‐point in the use of formalin‐fixed, paraffin tumor blocks to unveil kinase signaling in melanoma

31. The Human Melanoma Proteome Atlas—Complementing the melanoma transcriptome

32. The human melanoma proteome atlas—Defining the molecular pathology

33. Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease.

34. Proteogenomics Reveals how Metastatic Melanoma Modulates the Immune System to Allow Immune Evasion

35. Distinct sub-cellular autophagy impairments occur independently of protein aggregation in induced neurons from patients with Huntington’s disease

36. Proteomic Workflows for High-Quality Quantitative Proteome and Post-Translational Modification Analysis of Clinically Relevant Samples from Formalin-Fixed Paraffin-Embedded Archives

37. Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes

38. The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma—Association with Clinical Outcome and Tumor Phenotypes

40. Novel functional proteins coded by the human genome discovered in metastases of melanoma patients

42. GSTM3 and GSTP1: novel players driving tumor progression in cervical cancer

43. A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine againstN. meningitidisserogroup B and C

45. A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidisserogroup B and C

46. Proteomic Study to Survey the CIGB-552 Antitumor Effect.

47. Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes.

49. Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.

50. Mitochondrial dysfunction and immune suppression in BRAF V600E-mutated metastatic melanoma.

Catalog

Books, media, physical & digital resources